Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Applied Therapeutics Inc.Applied Therapeutics Reports Significant Cash Increase, Revenue Growth, and Net Loss in Latest Quarter
Vigil Neuroscience, Inc.Vigil Neuroscience Reports Q3 Financial Results, Net Loss of $19.3M
Akebia Therapeutics, Inc.Akebia Therapeutics Reports 11% Revenue Decline, Increased Net Losses in Q3 2024
Q32 Bio Inc.Q32 Bio Reports Significant Financial Changes Following Merger, Anticipates Continued Losses
Cartesian Therapeutics, Inc.Cartesian Therapeutics Reports Decline in Revenue, Net Loss, and Increased Cash Reserves in Latest 10-Q Filing
CHIMERIX INCChimerix Reports Mixed Financial Results, Focuses on Lead Product Development
Cullinan Therapeutics, Inc.Cullinan Therapeutics Reports Improved Financial Position, Net Loss in Latest Quarter
DIEBOLD NIXDORF, IncDiebold Nixdorf Reports Revenue Growth, Net Loss in Latest Quarter
Repare Therapeutics Inc.Repare Therapeutics Reports Q3 Financial Results, Net Loss Improves Amid Strategic Reprioritization and Reduced Expenses
TREVENA INCTrevena Reports Significant Financial Changes, Net Loss Improvement, and Strategic Adjustments in 10-Q Filing
DUCOMMUN INC /DE/Ducommun Incorporated Reports Strong Q3 and Nine-Month Financial Results with Revenue and Profitability Growth
BEYOND MEAT, INC.Beyond Meat Reports Mixed Q3 Results, Net Loss Narrows Amid Cost Reductions and Operational Challenges
Vivid Seats Inc.Vivid Seats Reports Mixed Q3 Results with Revenue Growth, Declining Profitability
Village Farms International, Inc.Village Farms International Reports 20% Revenue Growth, Improved Profitability in Q3 2024
Orthofix Medical Inc.Orthofix Medical Reports 6.8% Revenue Growth, Improved Profitability in Q3 2024
MidCap Financial Investment CorpMidCap Financial Investment Corporation Reports Strong Growth in Investment Income and Assets, Despite Rising Debt Costs
Zura Bio LtdZura Bio Reports Significant Financial Developments, Including 90% Increase in Operating Expenses and $188.2 Million in Cash and Cash Equivalents
Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics Reports Increased Collaboration Revenue and Reduced Losses, Enters Strategic Partnerships
First Watch Restaurant Group, Inc.First Watch Restaurant Group Reports 14.8% Revenue Growth, Net Income Decline in Q3 2024
MoonLake ImmunotherapeuticsMoonLake Immunotherapeutics Reports Significant Financial Developments, Net Loss Increases 210.8% in Latest Quarter
Chicago Atlantic Real Estate Finance, Inc.Chicago Atlantic Real Estate Finance Reports Mixed Q3 Results, Net Income Up 12%
IMMUNIC, INC.Immunic Reports Third Quarter Loss, Advances Clinical Programs and Leadership Team
Avalo Therapeutics, Inc.Avalo Therapeutics Reports Net Income Turnaround, Improved Cash Position, and Strategic Acquisitions in Q3 2024
EAGLE BANCORP INCEagle Bancorp Reports Mixed Q3 Results, Net Loss for Nine Months Due to Goodwill Impairment Charge
Dynatrace, Inc.Dynatrace Reports 19% Revenue Growth, Strong Operating Income and Cash Position in Q2 2024